Nymox Pharma (NYMX) Mentioned Cautiously by Feuerstein

October 11, 2016 10:25 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Nymox Pharma (NASDAQ: NYMX) was mentioned cautiously by theStreet's Adam Feuerstein on twitter. Earlier shares spiked after it announced successful new study results from the long-term repeated injection group from the U.S. Phase 3 trials for fexapotide.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Short Sales, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment